Cargando…
Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis
PURPOSE: Tocilizumab, a monoclonal IL-6 receptor blocker, is an effective agent for severe-to-critical cases of COVID-19; however, its target patients for the optimum use need to be detailed. We performed a systematic review and meta-analysis to define its effect among severely ill but non-intubated...
Autores principales: | Keske, Şiran, Akyol, Merve, Tanrıöver, Cem, Özlüşen, Batu, Akcan, Rüştü Emre, Güler, Ulaş, Sait, Bilgin, Kaçmaz, Bahar, Gönen, Mehmet, Ergönül, Önder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170028/ https://www.ncbi.nlm.nih.gov/pubmed/37162716 http://dx.doi.org/10.1007/s15010-023-02047-2 |
Ejemplares similares
-
Effectiveness of favipiravir in COVID-19: a live systematic review
por: Özlüşen, Batu, et al.
Publicado: (2021) -
National case fatality rates of the COVID-19 pandemic
por: Ergönül, Önder, et al.
Publicado: (2021) -
Appropriate use of tocilizumab in COVID-19 infection
por: Keske, Şiran, et al.
Publicado: (2020) -
COVID-19 associated bacterial infections in intensive care unit: a case control study
por: Kaçmaz, Bahar, et al.
Publicado: (2023) -
What is the ‘new normal’ in surgical procedures in the era of COVID-19?
por: Cimen, Cansu, et al.
Publicado: (2021)